Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Avenue
Dana Farber Cancer Institute
Boston, MA 02215Phone+1 617-632-3800Fax+1 617-632-1930
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 1999- Brigham and Women's HospitalResidency, Internal Medicine, 1993 - 1996
Perelman School of Medicine at the University of PennsylvaniaClass of 1993
Certifications & Licensure
MA State Medical License 1995 - 2026
NH State Medical License 2013 - 2026
CT State Medical License 2022 - 2025
ME State Medical License 2022 - 2025
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Melatonin Versus Placebo in Breast Cancer Start of enrollment: 2006 Oct 01
- Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy Start of enrollment: 2016 Dec 08
Publications & Presentations
PubMed
- Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (...Adrienne G Waks, Emily L Chen, Noah Graham, Anna Mae Frey, Kenneth Almeida
JCO Oncology Practice. 2025-03-01 - Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of D...Dario Trapani, Qingchun Jin, Kathy D Miller, Hope S Rugo, Katherine E Reeder-Hayes
Clinical Breast Cancer. 2024-12-31 - Awareness, Knowledge, and Treatment Patterns of Nonmetastatic Inflammatory Breast Cancer in Low- and Middle-Income Countries: The BRIDGES Study.Ilana Schlam, Kelly A Hirko, Daniela Shveid, Inas Abuali, Sarah Sewaralthahab
JCO Global Oncology. 2024-12-01
Lectures
- ABC trial (A011502): A randomized phase III double-blinded placebo controlled trial of aspirin as adjuvant therapy breast cancer.2019 ASCO Annual Meeting - 6/1/2019
Other
- Postmenopausal hormone therapy and the risk of breast cancerChen WY
http://www.uptodate.com/contents/postmenopausal-hormone-therapy-and-the-risk-of-breast-cancer
UpToDate, Wolters Kluwer Health - 2013-03-27 - Factors that modify breast cancer risk in womenChen WY, Costanza ME
http://www.uptodate.com/contents/factors-that-modify-breast-cancer-risk-in-women
UpToDate, Wolters Kluwer Health - 2012-11-15 - Selective estrogen receptor modulators and aromatase inhibitors for breast cancer preventionChen WY
http://www.uptodate.com/contents/selective-estrogen-receptor-modulators-and-aromatase-inhibitors-for
UpToDate, Wolters Kluwer Health - 2012-12-20
Press Mentions
Does Combination Menopausal Hormone Therapy Increase the Risk of Breast Cancer?November 4th, 2024- Aspirin vs Placebo as Adjuvant Therapy for Breast CancerApril 29th, 2024
- Could Aspirin Help Treat Breast Cancer?April 29th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
